{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:53:36Z","timestamp":1782849216267,"version":"3.54.5"},"reference-count":48,"publisher":"Pleiades Publishing Ltd","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochemistry Moscow"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Background. Chronic alcohol consumption in alcohol dependence (AD) is associated with various molecular and cellular dysfunctions. One of the key mechanisms involved is the extracellular release of HMGB1 (high-mobility group box\u00a01), a nuclear protein that acts as a proinflammatory signaling molecule. However, the dynamics of peripheral HMGB1 levels across different stages of AD and its association with psychopathological symptoms remain insufficiently understood. Objective. To investigate peripheral HMGB1 concentrations in patients with AD during different disease stages \u2013 alcohol withdrawal syndrome (AWS), post-abstinence state (PAS), and remission \u2013 and to assess their associations with clinical characteristics of the disease. Patients and Methods. The study included 53 men aged 30-60 years diagnosed with AD and 19 conditionally healthy men who served as controls for biological analyses. Clinical and biological assessments were performed at three time points: (1)\u00a0during AWS; (2)\u00a0after completion of standard therapy (PAS); and (3)\u00a0during remission following hospital discharge. The severity of psychopathological symptoms was evaluated using validated clinical rating scales. Serum HMGB1 concentrations were measured by enzyme-linked immunosorbent assay (ELISA). Results. Patients with AD demonstrated significantly elevated serum HMGB1 levels during AWS and PAS compared with controls, whereas HMGB1 concentrations decreased to control values during remission. Correlation and ROC analyses revealed that higher HMGB1 levels were associated with a less pronounced reduction in psychopathological symptoms following treatment. Conclusion. Peripheral HMGB1 may represent a promising biomarker for monitoring treatment response and predicting relapse risk in AD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1134\/s0006297926600237","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:04:21Z","timestamp":1782846261000},"page":"967-978","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HMGB1 Protein in Alcohol-Related Psychopathological Disorders at Various Stages of Alcohol Dependence"],"prefix":"10.1134","volume":"91","author":[{"given":"Tamara P.","family":"Vetlugina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena V.","family":"Epimakhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan V.","family":"Voevodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina D.","family":"Prokopieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay A.","family":"Bokhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"137","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"3049_CR1","first-page":"15","volume":"2-3","author":"I. P. Anokhina","year":"2017","unstructured":"Anokhina, I. P. (2017) The basic biological mechanisms of substance use disorders [in Russian], J.\u00a0Addict. Problems, 2-3, 15-41.","journal-title":"J.\u00a0Addict. Problems"},{"key":"3049_CR2","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1134\/S0006297924110026","volume":"89","author":"D. I. Peregud","year":"2024","unstructured":"Peregud, D. I., and Gulyaeva, N. V. (2024) Contribution of visceral systems to the development of substance use disorders: translational aspects of interaction between central and peripheral mechanisms, Biochemistry (Moscow), 89, 1868-1888, \nhttps:\/\/doi.org\/10.1134\/S0006297924110026.","journal-title":"Biochemistry (Moscow)"},{"key":"3049_CR3","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","volume":"3","author":"G. F. Koob","year":"2016","unstructured":"Koob, G. F., and Volkow, N. D. (2016) Neurobiology of addiction: a neurocircuitry analysis, Lancet Psychiatry, 3, 760-773, \nhttps:\/\/doi.org\/10.1016\/S2215-0366(16)00104-8.","journal-title":"Lancet Psychiatry"},{"key":"3049_CR4","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.neuron.2017.10.032","volume":"96","author":"K. P. Abrahao","year":"2017","unstructured":"Abrahao, K. P., Salinas, A. G., and Lovinger, D. M. (2017) Alcohol and the brain: neuronal molecular targets, synapses, and circuits, Neuron, 96, 1223-1238, \nhttps:\/\/doi.org\/10.1016\/j.neuron.2017.10.032.","journal-title":"Neuron"},{"key":"3049_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.25557\/1682-8313.2018.06.82-93","volume":"17","author":"A. G. Polunina","year":"2018","unstructured":"Polunina, A. G., and Bryun, E. A. (2018) Neural network activity against the background of acute and chronic alcohol intoxication, [in Russian], Narcology, 17, 82-93, \nhttps:\/\/doi.org\/10.25557\/1682-8313.2018.06.82-93.","journal-title":"Narcology"},{"key":"3049_CR6","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1134\/S0006297924110014","volume":"89","author":"N. V. Gulyaeva","year":"2024","unstructured":"Gulyaeva, N. V., and Peregud, D. I. (2024) An intricated pas de deux of addicted brain and body is orchestrated by stress and neuroplasticity, Biochemistry (Moscow), 89, 1863-1867, \nhttps:\/\/doi.org\/10.1134\/S0006297924110014.","journal-title":"Biochemistry (Moscow)"},{"key":"3049_CR7","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1053\/gast.2002.33613","volume":"122","author":"J. B. Hoek","year":"2002","unstructured":"Hoek, J. B., Cahill, A., and Pastorino, J. G. (2002) Alcohol and mitochondria: a dysfunctional relationship, Gastroenterology, 122, 2049-2063, \nhttps:\/\/doi.org\/10.1053\/gast.2002.33613.","journal-title":"Gastroenterology"},{"key":"3049_CR8","doi-asserted-by":"publisher","first-page":"26087","DOI":"10.3390\/ijms161125942","volume":"16","author":"S. Li","year":"2015","unstructured":"Li, S., Tan, H. Y., Wang, N., Zhang, Z. J., Lao, L., Wong, C.\u00a0W., and Feng, Y. (2015) The role of oxidative stress and antioxidants in liver diseases, Int. J. Mol. Sci., 16, 26087-26124, \nhttps:\/\/doi.org\/10.3390\/ijms161125942.","journal-title":"Int. J. Mol. Sci."},{"key":"3049_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.18097\/PBMC20236902083","volume":"69","author":"V. D. Prokopieva","year":"2023","unstructured":"Prokopieva, V. D., and Vetlugina, T. P. (2023) Features of oxidative stress in alcoholism, [in Russian], Biomed.Chem., 69, 83-96, \nhttps:\/\/doi.org\/10.18097\/PBMC20236902083.","journal-title":"Biomed.Chem."},{"key":"3049_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.26617\/1810-3111-2018-2(99)-28-32","volume":"2","author":"A. V. Solonsky","year":"2018","unstructured":"Solonsky, A. V., Prokopieva, V. D., and Yarygina, E. G. (2018) Neuromorphological and molecular effects of ethanol, [in Russian], Sib. J. Psychiatry Narcol., 2, 28-32, \nhttps:\/\/doi.org\/10.26617\/1810-3111-2018-2(99)-28-32.","journal-title":"Sib. J. Psychiatry Narcol."},{"key":"3049_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14030302","volume":"14","author":"L. Ruiter-Lopez","year":"2025","unstructured":"Ruiter-Lopez, L., Khan, M. A. S., Wang, X., and Song, B.\u00a0J. (2025) Roles of oxidative stress and autophagy in alcohol-mediated brain damage, Antioxidants (Basel), 14, 302, \nhttps:\/\/doi.org\/10.3390\/antiox14030302.","journal-title":"Antioxidants (Basel)"},{"key":"3049_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.smim.2018.02.011","volume":"38","author":"U. Andersson","year":"2018","unstructured":"Andersson, U., Yang, H., and Harris, H. (2018) High-mobility group box\u00a01 protein (HMGB1) operates as an alarmin outside as well as inside cells, Semin. Immunol., 38, 40-48, \nhttps:\/\/doi.org\/10.1016\/j.smim.2018.02.011.","journal-title":"Semin. Immunol."},{"key":"3049_CR13","doi-asserted-by":"publisher","first-page":"716","DOI":"10.31857\/S0041377120100016","volume":"62","author":"E. V. Chikhirzhina","year":"2020","unstructured":"Chikhirzhina, E. V., Polyani\u010dko, A. M., and Starkova, T. Yu. (2020) Extranuclear functions of the non-histone protein HMGB1 [in Russian], Cell Tissue Biol., 62, 716-725, \nhttps:\/\/doi.org\/10.31857\/S0041377120100016.","journal-title":"Cell Tissue Biol."},{"key":"3049_CR14","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41577-023-00894-6","volume":"23","author":"D. Tang","year":"2023","unstructured":"Tang, D., Kang, R., Zeh, H. J., and Lotze, M.\u00a0T. (2023) The multifunctional protein HMGB1: 50 years of discovery, Nat. Rev. Immunol., 23, 824-841, \nhttps:\/\/doi.org\/10.1038\/s41577-023-00894-6.","journal-title":"Nat. Rev. Immunol."},{"key":"3049_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2015.03.010","volume":"48","author":"M. G. Frank","year":"2015","unstructured":"Frank, M. G., Weber, M. D., Watkins, L. R., Maier, S. F. (2015) Stress sounds the alarmin: the role of the danger-associated molecular pattern HMGB1 in stress-induced neuroinflammatory priming, Brain Behav. Immun., 48, 1-7, \nhttps:\/\/doi.org\/10.1016\/j.bbi.2015.03.010.","journal-title":"Brain Behav. Immun."},{"key":"3049_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s12276-022-00736-w","volume":"54","author":"R. Chen","year":"2022","unstructured":"Chen, R., Kang, R., and Tang, D. (2022) The mechanism of HMGB1 secretion and release, Exp. Mol. Med., 54, 91-102, \nhttps:\/\/doi.org\/10.1038\/s12276-022-00736-w.","journal-title":"Exp. Mol. Med."},{"key":"3049_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/01.shk.0000225404.51320.82","volume":"26","author":"M. Yu","year":"2006","unstructured":"Yu, M., Wang, H., Ding, A., Golenbock, D.\u00a0T., Latz, E., Czura, C.\u00a0J., Fenton, M.\u00a0J., Tracey, K.\u00a0J., and Yang, H. (2006) HMGB1 signals through Toll-like Receptor (TLR) 4 and TLR2, Shock, 26, 174-179, \nhttps:\/\/doi.org\/10.1097\/01.shk.0000225404.51320.82.","journal-title":"Shock"},{"key":"3049_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.intimp.2010.11.014","volume":"11","author":"Y. Ling","year":"2011","unstructured":"Ling, Y., Yang, Z. Y., Yin, T., Li, L., Yuan, W. W., Wu, H. S., Wang, C. Y. (2011) Heparin changes the conformation of high-mobility group protein\u00a01 and decreases its affinity toward receptor for advanced glycation end products in\u00a0vitro, Int. Immunopharmacol., 11, 187-193, \nhttps:\/\/doi.org\/10.1016\/j.intimp.2010.11.014.","journal-title":"Int. Immunopharmacol."},{"key":"3049_CR19","doi-asserted-by":"publisher","first-page":"15659","DOI":"10.1096\/fj.202002136R","volume":"34","author":"D. Prantner","year":"2020","unstructured":"Prantner, D., Nallar, S., and Vogel, S.\u00a0N. (2020) The role of RAGE in host pathology and crosstalk between RAGE and TLR4 in innate immune signal transduction pathways, FASEB\u00a0J., 34, 15659-15674, \nhttps:\/\/doi.org\/10.1096\/fj.202002136R.","journal-title":"FASEB\u00a0J."},{"key":"3049_CR20","doi-asserted-by":"publisher","DOI":"10.35946\/arcr.v44.1.04","volume":"44","author":"F.\u00a0T. Crews","year":"2024","unstructured":"Crews, F.\u00a0T., Coleman, L.\u00a0G., Jr., Macht, V.\u00a0A., Vetreno, R.\u00a0P. (2024) Alcohol, HMGB1, and innate immune signaling in the brain, Alcohol Res., 44, 04, \nhttps:\/\/doi.org\/10.35946\/arcr.v44.1.04.","journal-title":"Alcohol Res."},{"key":"3049_CR21","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.3390\/biom5042573","volume":"5","author":"S. Patel","year":"2015","unstructured":"Patel, S., Behara, R., Swanson, G., Forsyth, C., Voigt, R., and Keshavarzian, A. (2015) Alcohol and the intestine, Biomolecules, 5, 2573-2588, \nhttps:\/\/doi.org\/10.3390\/biom5042573.","journal-title":"Biomolecules"},{"key":"3049_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.35946\/arcr.v38.2.02","volume":"38","author":"F. Bishehsari","year":"2017","unstructured":"Bishehsari, F., Magno, E., Swanson, G., Desai, V., Voigt, R.\u00a0M., Forsyth, C.\u00a0B., and Keshavarzian, A. (2017) Alcohol and gut-derived inflammation, Alcohol Res., 38, 163-171, \nhttps:\/\/doi.org\/10.35946\/arcr.v38.2.02.","journal-title":"Alcohol Res."},{"key":"3049_CR23","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2022.12858","volume":"26","author":"A. Kawase","year":"2022","unstructured":"Kawase, A., Irie, K., Matsuda, N., Takai, Y., Shimada, H., and Iwaki, M. (2022) Distinct roles of HMGB1 in the regulation of P-glycoprotein expression in the liver and kidney of mice with lipopolysaccharide-induced inflammation, Mol. Med. Rep., 26, 342, \nhttps:\/\/doi.org\/10.3892\/mmr.2022.12858.","journal-title":"Mol. Med. Rep."},{"key":"3049_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2024.05.010","volume":"18","author":"X. Ge","year":"2024","unstructured":"Ge, X., Han, H., Desert, R., Das, S., Song, Z., Komakula, S.\u00a0S.\u00a0B., Chen, W., Athavale, D., Lantvit, D., and Nieto, N. (2024) A protein complex of liver origin activates a pro-inflammatory program that drives hepatic and intestinal injury in alcohol-associated liver disease, Cell. Mol. Gastroenterol. Hepatol., 18, 101362, \nhttps:\/\/doi.org\/10.1016\/j.jcmgh.2024.05.010.","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"3049_CR25","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/apm.12568","volume":"124","author":"T. L. Laursen","year":"2016","unstructured":"Laursen, T. L., St\u00f8y, S., Deleuran, B., Vilstrup, H., Gr\u00f8nbaek, H., and Sandahl, T.\u00a0D. (2016) The damage-associated molecular pattern HMGB1 is elevated in human alcoholic hepatitis, but does not seem to be a primary driver of inflammation, APMIS, 124, 741-747, \nhttps:\/\/doi.org\/10.1111\/apm.12568.","journal-title":"APMIS"},{"key":"3049_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.alcohol.2021.05.003","volume":"95","author":"A. G. L. Vannier","year":"2021","unstructured":"Vannier, A. G. L., Wardwell, B., Fomin, V., PeBenito, A., Wolczynski, N., Piaker, S., Kedrin, D., Chung, R. T., Schaefer, E., Goodman, R., Patel, S.\u00a0J., and Luther, J. (2021) Serum HMGB1 associates with liver disease and predicts readmission and mortality in patients with alcohol use disorder, Alcohol, 95, 37-43, \nhttps:\/\/doi.org\/10.1016\/j.alcohol.2021.05.003.","journal-title":"Alcohol"},{"key":"3049_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/toxics12030190","volume":"12","author":"F. Rodriguez De Fonseca","year":"2024","unstructured":"Rodriguez De Fonseca, F., Medina-Paz, F., Sapozhnikov, M., Hurtado-Guerrero, I., Rubio, Leticia, Martin-de-Las-Heras, S., Requena-Oca\u00f1a, N., Flores-L\u00f3pez, M., Del Mar Fern\u00e1ndez-Arjona, M., Rivera, P., Serrano, A., Serrano, P., Zapico, S.\u00a0C., and Su\u00e1rez, J. (2024) Plasma concentrations of high mobility group box\u00a01 proteins and soluble receptors for advanced glycation end-products are relevant biomarkers of cognitive impairment in alcohol use disorder: a pilot study, Toxics, 12, 190, \nhttps:\/\/doi.org\/10.3390\/toxics12030190.","journal-title":"Toxics"},{"key":"3049_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s43045-025-00537-7","volume":"32","author":"A. S. Tolmacheva","year":"2025","unstructured":"Tolmacheva, A. S., Bobrik, D. V., Melamud, M. M., Efremov, I.\u00a0S., Nevinsky, G.\u00a0A., Buneva, V.\u00a0N., Akhmetova, E.\u00a0A., Asadullin, A.\u00a0R., and Ermakov, E.\u00a0A. (2025) High-mobility group protein\u00a0B1 (HMGB1) level in plasma of alcohol use disorder patients in withdrawal state, Middle East Curr. Psychiatry, 32, 41, \nhttps:\/\/doi.org\/10.1186\/s43045-025-00537-7.","journal-title":"Middle East Curr. Psychiatry"},{"key":"3049_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"A. S. Zigmond","year":"1983","unstructured":"Zigmond, A. S., and Snaith, R. P. (1983) The hospital anxiety and depression scale, Acta Psychiatr. Scand., 67, 361-370, \nhttps:\/\/doi.org\/10.1111\/j.1600-0447.1983.tb09716.x.","journal-title":"Acta Psychiatr. Scand."},{"key":"3049_CR30","unstructured":"Dubinina, L. A., Rybakova, K. V., Rybakova, T. G., Bakman, I. Yu., Kisilev, A. S., Erychev, O. F., and Krupitsky, E. M. (2012) Clinical and Socio-Psychological Criteria for Evaluating the Readaptation of Patients with Alcohol Dependence at the Stages of Remission Formation: A Guide for Physicians, V.\u00a0M. Bekhterev National Research Institute of Psychiatry and Neurology, St. Petersburg, Russia."},{"key":"3049_CR31","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1111\/j.1530-0277.1999.tb04349.x","volume":"23","author":"B. A. Flannery","year":"1999","unstructured":"Flannery, B. A., Volpicelli, J. R., and Pettinati, H.\u00a0M. (1999) Psychometric properties of the Penn alcohol craving scale, Alcohol Clin. Exp. Res., 23, 1289-1295, \nhttps:\/\/doi.org\/10.1111\/j.1530-0277.1999.tb04349.x.","journal-title":"Alcohol Clin. Exp. Res."},{"key":"3049_CR32","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.biopsych.2012.09.030","volume":"73","author":"F. T. Crews","year":"2013","unstructured":"Crews, F. T., Qin, L., Sheedy, D., Vetreno, R. P., and Zou, J. (2013) High mobility group box\u00a01\/Toll-like receptor danger signaling increases brain neuroimmune activation in alcohol dependence, Biol. Psychiatry, 73, 602-612, \nhttps:\/\/doi.org\/10.1016\/j.biopsych.2012.09.030.","journal-title":"Biol. Psychiatry"},{"key":"3049_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0799-4","volume":"14","author":"L. G. Coleman Jr.","year":"2017","unstructured":"Coleman, L. G., Jr., Zou, J., and Crews, F. (2017) Microglial-derived miRNA Let-7 and HMGB1 contribute to ethanol-induced neurotoxicity via TLR7, J.\u00a0Neuroinflammation, 14, 22, \nhttps:\/\/doi.org\/10.1186\/s12974-017-0799-4.","journal-title":"J.\u00a0Neuroinflammation"},{"key":"3049_CR34","doi-asserted-by":"publisher","first-page":"95","DOI":"10.18097\/PBMC20216701095","volume":"67","author":"M. I. Airapetov","year":"2021","unstructured":"Airapetov, M. I., Eresko, S. O., Bychkov, E. R., Lebedev, A. A., and Shabanov, P. D. (2021) Expression of the HMGB1 gene changes in the striatum and amygdala of rat brain during long-term alcoholization and ethanol withdrawal [in Russian], Biomed. Chem., 67, 95-99, \nhttps:\/\/doi.org\/10.18097\/PBMC20216701095.","journal-title":"Biomed. Chem."},{"key":"3049_CR35","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1164\/ajrccm.164.10.2106117","volume":"164","author":"H. Wang","year":"2001","unstructured":"Wang, H., Yang, H., Czura, C.\u00a0J., Sama, A.\u00a0E., and Tracey, K.\u00a0J. (2001) HMGB1 as a late mediator of lethal systemic inflammation, Am. J. Respir. Crit. Care Med., 164, 1768-1773, \nhttps:\/\/doi.org\/10.1164\/ajrccm.164.10.2106117.","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"3049_CR36","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.bbi.2023.04.018","volume":"111","author":"W. A. Banks","year":"2023","unstructured":"Banks, W. A., Hansen, K. M., Erickson, M. A., Crews, F.\u00a0T. (2023) High-mobility group box\u00a01 (HMGB1) crosses the BBB bidirectionally, Brain Behav. Immun., 111, 386-394, \nhttps:\/\/doi.org\/10.1016\/j.bbi.2023.04.018.","journal-title":"Brain Behav. Immun."},{"key":"3049_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13010067","volume":"13","author":"S. Shukla","year":"2025","unstructured":"Shukla, S., and Hsu, C. L. (2025) Alcohol use disorder and the gut-brain axis: a narrative review of the role of gut microbiota and implications for treatment, Microorganisms, 13, 67, \nhttps:\/\/doi.org\/10.3390\/microorganisms13010067.","journal-title":"Microorganisms"},{"key":"3049_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.15","volume":"7","author":"S. Leclercq","year":"2017","unstructured":"Leclercq, S., de Timary, P., Delzenne, N. M., and St\u00e4rkel, P. (2017) The link between inflammation, bugs, the intestine and the brain in alcohol dependence, Transl. Psychiatry, 7, e1048, \nhttps:\/\/doi.org\/10.1038\/tp.2017.15.","journal-title":"Transl. Psychiatry"},{"key":"3049_CR39","first-page":"215","volume":"19","author":"N. A. Didkovsky","year":"2018","unstructured":"Didkovsky, N. A., Malashenkova, I. K., Ogurtsov, D. P., Krynskiy, S. A., Babaeva, L. A. (2018) Neuroimmune mechanisms of alcoholism [in Russian], Allergolog, Immunol., 19, 215-221.","journal-title":"Allergolog, Immunol."},{"key":"3049_CR40","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2569740","volume":"17","author":"Y. Ru","year":"2025","unstructured":"Ru, Y., Jia, J., Yang, X., Ba, X., Yan, J., Zhang, H., and Zhang, Y. (2025) From bugs to behavior: targeting the gut-brain interface for addiction therapeutics, Gut Microbes, 17, 2569740, \nhttps:\/\/doi.org\/10.1080\/19490976.2025.2569740.","journal-title":"Gut Microbes"},{"key":"3049_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2014.08.007","volume":"44","author":"W. A. Banks","year":"2015","unstructured":"Banks, W. A. (2015) The blood-brain barrier in neuroimmunology: tales of separation and assimilation, Brain Behav. Immun., 44, 1-8, \nhttps:\/\/doi.org\/10.1016\/j.bbi.2014.08.007.","journal-title":"Brain Behav. Immun."},{"key":"3049_CR42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pbb.2018.12.007","volume":"177","author":"E.\u00a0K. Erickson","year":"2019","unstructured":"Erickson, E.\u00a0K., Grantham, E.\u00a0K., Warden, A.\u00a0S., and Harris, R. A. (2019) Neuroimmune signaling in alcohol use disorder, Pharmacol. Biochem. Behav., 177, 34-60, \nhttps:\/\/doi.org\/10.1016\/j.pbb.2018.12.007.","journal-title":"Pharmacol. Biochem. Behav."},{"key":"3049_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/nu13113938","volume":"13","author":"D. Nutt","year":"2021","unstructured":"Nutt, D., Hayes, A., Fonville, L., Zafar, R., Palmer, E.\u00a0O.\u00a0C., Paterson, L., and Lingford-Hughes, A. (2021) Alcohol and the brain, Nutrients, 13, 3938, \nhttps:\/\/doi.org\/10.3390\/nu13113938.","journal-title":"Nutrients"},{"key":"3049_CR44","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/adb.12543","volume":"23","author":"L. Orio","year":"2018","unstructured":"Orio, L., Anton, M., Rodriguez-Rojo, I.\u00a0C., Correas, A., Garc\u00eda-Bueno, B., Corral, M., Rodr\u00edguez de Fonseca, F., Garc\u00eda-Moreno, L.\u00a0M., Maest\u00fa, F., and Cadaveiraet, F. (2018) Young alcohol binge drinkers have elevated blood endotoxin, peripheral inflammation and low cortisol levels: neuropsychological correlations in women, Addict. Biol., 23, 1130-1144, \nhttps:\/\/doi.org\/10.1111\/adb.12543.","journal-title":"Addict. Biol."},{"key":"3049_CR45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bbi.2017.10.027","volume":"72","author":"L. G. Coleman Jr.","year":"2018","unstructured":"Coleman, L. G., Jr., Zou, J., Qin, L., and Crews, F.\u00a0T. (2018) HMGB1\/IL-1beta complexes regulate neuroimmune responses in alcoholism, Brain Behav. Immun., 72, 61-77, \nhttps:\/\/doi.org\/10.1016\/j.bbi.2017.10.027.","journal-title":"Brain Behav. Immun."},{"key":"3049_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00484","volume":"11","author":"H. Yang","year":"2020","unstructured":"Yang, H., Wang, H., and Andersson, U. (2020) Targeting inflammation driven by HMGB1, Front. Immunol., 11, 484, \nhttps:\/\/doi.org\/10.3389\/fimmu.2020.00484.","journal-title":"Front. Immunol."},{"key":"3049_CR47","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s12026-022-09295-8","volume":"70","author":"D. Ghosh","year":"2022","unstructured":"Ghosh, D., Singh, A., Kumar, A., and Sinha, N. (2022) High mobility group box\u00a01 (HMGB1) inhibition attenuates lipopolysaccharide-induced cognitive dysfunction and sickness-like behavior in mice, Immunol. Res., 70, 633-643, \nhttps:\/\/doi.org\/10.1007\/s12026-022-09295-8.","journal-title":"Immunol. Res."},{"key":"3049_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092220","volume":"10","author":"C. S. Zhu","year":"2021","unstructured":"Zhu, C. S., Wang, W., Qiang, X., Chen, W., Lan, X., Li, J., and Wang, H. (2021) Endogenous regulation and pharmacological modulation of sepsis-induced HMGB1 release and action: an updated review, Cells, 10, 2220, \nhttps:\/\/doi.org\/10.3390\/cells10092220.","journal-title":"Cells"}],"container-title":["Biochemistry (Moscow)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297926600237.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S0006297926600237","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297926600237.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:04:28Z","timestamp":1782846268000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S0006297926600237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["3049"],"URL":"https:\/\/doi.org\/10.1134\/s0006297926600237","relation":{},"ISSN":["0006-2979","1608-3040"],"issn-type":[{"value":"0006-2979","type":"print"},{"value":"1608-3040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent to participate.\n                      All procedures performed in studies involving human participants were in accordance with the ethical standards of the national research ethics committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed voluntary consent was obtained from each participant included in the study. The study was approved by the Local Ethics Committee at the Mental Health Research Institute, Tomsk National Research Medical Center (Protocol no.\u00a0181; February\u00a011, 2025; case no.\u00a0181\/1.2025).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Conflict of interest.\n                      The authors of this work declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}]}}